Apella, a San Francisco, CA-based technology company dedicated to improving surgery, raised $21m in Series A funding.
The round was led by Casdin Capital, who was joined by Vensana Capital, PFM Health Sciences, Twine Ventures, Upside Partnership, and Operator Partners as well as a number of notable individual investors.
The company intends to use the funds to expand implementation of its technology with hospital partners, to grow its team and to develop new applications based on its core platform and computer vision and machine learning capabilities.
Led by David Schummers, co-founder and CEO, Apella has develped technology that harnesses artificial intelligence to create a systematic method for process improvement and quality control in surgery. Its sensors, installed in the operating room, harness a variety of artificial intelligence approaches to collect and analyze new data about surgery. This data contributes to applications targeted at improving hospital operations, surgical quality, staff training and real-time decision making with the overall goal of improving the quality of surgical care.